#3811
Re: Seguimiento acciones empresas alto crecimiento: NAGARRO SE (NA9)
Zynex (NASDAQ: ZYXI), a medical technology company focused on non-invasive medical devices, has announced significant leadership changes with the arrival of Steven Dyson as CEO and several key executive appointments effective August 18, 2025.
The new leadership team includes Vikram Bajaj as CFO, bringing 20 years of med-tech sector experience, John T. Bibb as Chief Legal Officer with extensive legal and compliance background, Ajay Gopal as EVP of Sales with proven commercial leadership experience, and Agnes Powell as VP of Billing with 20 years in revenue cycle operations.
The executive leadership team will be completed by existing members Anna Lucsok (COO) and Donald Gregg (President of Zynex Monitoring Solutions). Chairman Thomas Sandgaard expressed confidence in the new team's ability to lead Zynex to new levels of success.
Sigue un -5% las perdidas en los ultimos 5 dias, asi que no veo mucha confianza en el mercado por estos movimientos... el tiempo dira :).
Saludos
Sigue un -5% las perdidas en los ultimos 5 dias, asi que no veo mucha confianza en el mercado por estos movimientos... el tiempo dira :).
Saludos